Device Trial Radar · NCT02085278
Safety of Apollo Micro Catheter in Pediatric Patients
Last checked: Nov 20, 2026Latest source record: Jan 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Feb 2014
Primary completion
Jun 2015
Study completion Jun 2015
Sponsor
- Lead sponsor
- St. Luke's-Roosevelt Hospital CenterAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Mar 12, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Device feasibility
- Who can join
- All sexes, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical trial/study for patients diagnosed with brain arteriovenous malformation (AVM). An AVM is an abnormal connection between the arteries and veins of the brain. Patients considered for this trial are 21 years and younger with AVM suitable for embolization treatment (a procedure used to block the abnormal connection between the arteries and veins of the brain) with Onyx Liquid Embolic System (Onyx LES) or TruFill n-Butyl Cyanoacrylate (n-BCA) Liquid Embolic System (both are liquid substances used in the embolization procedure to block the abnormal connection).
Conditions
- Brain Arteriovenous Malformation
- Brain Vascular Malformations
- Vein of Galen Malformation
Interventions
Apollo Micro Catheter deviceDevice
Detachable Tip Micro catheter
Primary outcomes
What the sponsor says the trial is designed to measure.
- The study's primary endpoint is the incidence of catheter entrapment.Time frame: Within 24 hours after embolization
Locations
1 site in 1 country. Site status is shown where the registry gives one.
St.Luke's-Roosevelt Hospital
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.